Lacidipine: Difference between revisions

Lacidipine
Clinical data
ATC code	C08CA09 (WHO) ;
Identifiers
	IUPAC name diethyl 2,6-dimethyl-4-[2-[(E)-3- [(2-methylpropan-2-yl)oxy]-3-oxoprop- 1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate;
PubChem CID	5311217;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C26H33NO6
Molar mass	455.543 g/mol

Revision as of 16:45, 9 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Lacidipine (tradenames Lacipil, Motens) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.

@@ Line 26: / Line 26: @@
 {{CMG}}
-{{Editor Join}}
 '''Lacidipine''' (tradenames '''Lacipil''', '''Motens''') is a [[calcium channel blocker]]. It is available as tablets containing 2 or 4 mg.

Clinical data

ATC code	C08CA09 (WHO)
Identifiers
IUPAC name diethyl 2,6-dimethyl-4-[2-[(E)-3- [(2-methylpropan-2-yl)oxy]-3-oxoprop- 1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate
PubChem CID	5311217
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₆H₃₃NO₆
Molar mass	455.543 g/mol